McKesson Corporation MCK

866.64 (2.72) (0.31%) as of 25 Sep
Market cap
$101.8B
P/E
23.1×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

McKesson Corporation (MCK) EV/EBITDA

As of 25 September 2026, McKesson Corporation (MCK) trades at a EV/EBITDA of 15.5×. Over the past ten years it has ranged from 0.0× (December 2021) to 21.8× (November 2024); the current reading is higher than 71% of that period. That is in line with the Medical Distribution industry median of 15.5× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2026 16.5× (8.53%)
FY2025 18.1× 4.33%
FY2024 17.3× 49.39%
FY2023 11.6× (42.33%)
FY2022 20.1× —
FY2021 0.0× —
FY2020 7.8× 9.69%
FY2019 7.1× (18.17%)
FY2018 8.7× 88.46%
FY2017 4.6× (48.93%)

Quarterly

Period EV/EBITDA Change
Jun 2026 13.7× (17.17%)
Mar 2026 16.5× (4.68%)
Dec 2025 17.3× (2.24%)
Sep 2025 17.7× (12.65%)
42 more quarters

Against its own ten years

Low 0.0× High 21.8×
Ten-year median 10.4×
Current reading's percentile 71

EV/EBITDA against peers

Company EV/EBITDA
COSM Cosmos Health Inc. compare n/m
FOCL FocalTherics compare n/m
AHG Akso Health Group Sponsored ADR compare n/m
YI 111, Inc. Sponsored ADR compare n/m
ACH Accendra Health, Inc. compare 8.2×
HSIC Henry Schein, Inc. compare 12.0×
MCK McKesson Corporation 15.5×
CAH Cardinal Health, Inc. compare 15.7×
COR Cencora, Inc. compare 16.6×
Medical Distribution industry median 15.5×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on MCK